Briefs: Indoco Remedies and Panacea Biotec

Panacea Biotec receives LoA from CMSS

SRMIST to host global physiotherapy and hand rehabilitation conclave on 16-18 April

The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students

Actinium Pharma unveils groundbreaking data on radiotherapy platform at AACR 2026

The presentations will showcase previously undisclosed data highlighting the expanding potential of Actinium’s Ac-225 radiotherapy platform across both solid tumors and hematologic malignancies

Exclusive | Bharat Biotech’s ROTAVAC halves severe diarrhoea hospitalisations in children, landmark Nature study confirms

Nature Medicine study delivers strongest real-world evidence yet for India’s indigenous rotavirus vaccine under UIP

Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies

Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy

BioE3 policy accelerates India’s biomanufacturing ambitions with biofoundries, AI hubs & space biotech

Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors

Nearly 40 industry groups unite to push for EU Biotech Act II

A joint position paper warns that Europe is the only major global region without a dedicated biomanufacturing initiative

Lilly to acquire sleep drug biotech firm Centessa in $6.3 billion deal

The company’s broader OX2R portfolio includes clinical and preclinical assets with potential applications across neurological, neurodegenerative, and neuropsychiatric conditions

Wockhardt’s breakthrough antibiotic Zaynich wins key regulatory nod in India

Siemens Healthineers expands radiotherapy beyond cancer, targets osteoarthritis pain

The radiotherapy systems include TrueBeam, TrueBeam STx, VitalBeam, and Edge